Evaluating Diuretics in Normal Care (EVIDENCE) - A Cluster Randomised Evaluation of Prescribing Policy for Hypertension

Medicine & Life Sciences

1. Sodium Chloride Symporter Inhibitors 100%
2. Equivalence Trials 98%
3. Diuretics 73%
4. Randomized Controlled Trials 49%
5. Hypertension 48%
6. Safety 34%
7. Bendroflumethiazide 24%
8. Indapamide 22%
9. Myocardial Infarction 21%
10. Research Ethics 20%
11. Peer Review 18%
12. Delivery of Health Care 18%
13. Scotland 17%
14. National Health Programs 15%
15. Ethics 15%
16. Organizations 12%
17. Datasets 11%
18. Primary Health Care 11%
19. Hospitalization 10%
20. Heart Failure 10%
21. Public Health 10%
22. Clinical Trials 9%
23. Guidelines 9%
24. Pharmaceutical Preparations 6%
25. Population 5%